Skip to content

    NEUROONE MEDICAL TECHNOLOGIES (NMTC) stock price & financials

    View NMTC earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance60.7% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $272.3K
    $3.27M
    $1.39M
    $1.70M
    $2.74M
    +906.6%
    $2.89M
    -11.7%
    $1.86M
    +34.3%
    $1.97M
    +16.3%
    Strengthening
    Operating Profit
    -$2.82M
    $1.71M
    -$2.68M
    -$1.89M
    -$1.37M
    +51.3%
    -$1.71M
    -199.8%
    -$2.40M
    +10.6%
    -$2.42M
    -28.5%
    Weakening
    Net Profit
    -$3.35M
    $1.79M
    -$2.27M
    -$1.50M
    -$1.62M
    +51.7%
    -$1.44M
    -180.5%
    -$2.38M
    -4.9%
    -$2.01M
    -33.7%
    Weakening
    EPS
    $0.06
    $-0.44
    $-0.19
    $-0.03
    -150.0%
    $-0.28
    +36.4%
    $-0.23
    -21.1%
    Weakening
    Other Income
    Interest
    Depreciation
    Profit before Tax
    -$3.35M
    $1.79M
    -$2.27M
    -$1.50M
    -$1.62M
    +51.7%
    -$1.44M
    -180.5%
    -$2.38M
    -4.9%
    -$2.01M
    -33.7%
    Weakening
    MarginsOPM
    -1034.5%
    52.3%
    -193.3%
    -111.2%
    -50.0%
    +95.2%
    -59.0%
    -212.9%
    -128.7%
    +33.4%
    -122.9%
    -10.5%
    Weakening
    Tax
    ReturnsROIC
    4.0%
    -2.1%
    2.7%
    1.8%
    1.9%
    -51.7%
    1.7%
    2.8%
    +4.9%
    2.4%
    +33.7%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY17FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$26.5K$260.7K$4.04M$6.90M$8.16M$5.32M$1.46M$6.57M$2.05M
    Short-Term Investments
    Total Current Assets$33.6K$301.8K$4.16M$7.29M$12.18M$7.31M$4.63M$10.23M$5.79M
    Net PP&E$52.0K$448.2K$512.3K$535.0K$694.8K$671.8K$514.4K$369.1K
    Goodwill
    Intangibles$216.4K$178.8K$156.5K$134.2K$111.9K$89.6K$67.3K$44.9K$28.2K
    Total Assets$250.0K$532.6K$4.76M$7.94M$12.82M$8.10M$5.37M$10.79M$6.19M
    LiabilitiesTotal Current Liabilities$3.91M$1.77M$2.36M$1.18M$3.10M$1.79M$2.21M$2.30M$2.04M
    Short-Term Debt$253.0K$1.01M$129.1K
    Long-Term Debt
    Long-Term Leases$254.3K$202.9K$119.6K$55.3K$194.4K$143.1K$73.3K
    Total Liabilities$5.29M$1.77M$2.69M$1.38M$3.22M$1.85M$4.55M$3.71M$2.42M
    EquityCommon Stock & APIC$7.9K$13.5K$22.2K$12.0K$16.2K$23.9K$30.8K$8.3K$8.7K
    Retained Earnings-$5.32M-$17.24M-$30.88M-$40.83M-$50.83M-$62.69M-$75.00M-$78.61M-$84.44M
    Total Equity-$5.04M-$1.24M$2.07M$6.55M$9.60M$6.25M$822.0K$7.07M$3.77M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY17FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$2.11M-$5.40M-$3.43M-$8.60M-$7.52M-$12.89M-$11.01M-$2.84M-$7.05M
    Cash from Investing-$91.7K-$123.4K-$122.4K-$67.1K-$3.24M$2.65M-$120.2K-$81.7K-$109.5K
    Cash from Financing$1.70M$5.77M$7.32M$11.53M$12.02M$7.40M$7.27M$8.03M$1.17M
    SummaryCapital Expenditure-$58.4K-$122.4K-$67.1K-$275.2K-$384.1K-$120.2K-$81.7K-$109.5K
    Free Cash Flow-$5.45M-$3.55M-$8.67M-$7.79M-$13.27M-$11.13M-$2.92M-$7.16M
    FCF Margin-4866.7%-4553.8%-679.7%-322.4%-32.1%-75.6%

    Ratios